Table 2.
Case | Age (years) | Gender | RET mutation | CEACAM1 expression |
---|---|---|---|---|
1 | 60 | F | Negative | Positive |
2 | 65 | M | Negative | Positive |
3 | 51 | F | Negative | Positive |
4 | 66 | F | Negative | Positive |
5 | 32 | F | Negative | Negative |
6 | 64 | F | Negative | Positive |
7 | 54 | F | Positive (MEN) | Positive |
8 | 36 | F | Positive (MEN) | Positive |
9 | 26 | F | Positive (MEN) | Positive |
10 | 26 | F | Negative | Positive |
11 | 61 | M | Negative | Positive |
12 | 44 | F | Positive (sporadic) | Positive |
13 | 42 | F | Positive (MEN) | Positive |
14 | 66 | M | Negative | Negative |
15 | 64 | F | Negative | Negative |
16 | 38 | F | Negative | Positive |
17 | 9 | F | Positive (sporadic) | Positive |
18 | 54 | F | Negative | Negative |
19 | 36 | M | Negative | Negative |
20 | 61 | F | Positive (sporadic) | Positive |
21 | 77 | F | Negative | Negative |
22 | 80 | M | Negative | Positive |
All cases were immunohistochemically calcitonin‐positive.
MEN; multiple endocrine neoplasia syndrome.